As of June 20, 2025, FluoroPharma Medical Inc (FPMI) reports a Current Ratio of 0.00.
Current Ratio assesses a company's ability to pay short-term debts by comparing liquid assets to liabilities, with higher ratios signaling better financial health.
Historical Trend of FluoroPharma Medical Inc's Current Ratio
Over recent years, FluoroPharma Medical Inc's Current Ratio has shown significant volatility. The table below summarizes the historical values:
| Date | Current Ratio |
|---|---|
| 2016-12-31 | 0.00 |
| 2015-12-31 | 0.06 |
| 2014-12-31 | 0.08 |
| 2013-12-31 | 0.62 |
| 2012-12-31 | 5.87 |
This gradual decrease highlights how FluoroPharma Medical Inc manages its short-term assets and liabilities over time.
Comparing FluoroPharma Medical Inc's Current Ratio to Peers
To better understand FluoroPharma Medical Inc's position, it's useful to compare its Current Ratio against industry peers. Below are selected comparisons:
| Company | Current Ratio |
|---|---|
| FluoroPharma Medical Inc (FPMI) | 0.00 |
| Caladrius Biosciences Inc (CLBS) | 21.27 |
| Karuna Therapeutics Inc (KRTX) | 19.31 |
| Rocket Pharmaceuticals Inc (RCKT) | 9.30 |
| Panacos Pharmaceuticals Inc (PANC) | 7.23 |
| ZIOPHARM Oncology Inc (ZIOP) | 7.11 |
Compared to its competitors, FluoroPharma Medical Inc's Current Ratio is among the lowest compared to peers, suggesting tighter liquidity management or potential short-term obligations concerns.